Background and Purpose-Atherosclerosis is a systemic disease, and both coronary and intracranial atherosclerosis are common in the elderly. Unlike coronary artery disease (CAD), intracranial atherosclerotic disease can cause intracranial atherosclerotic stroke by branch occlusive disease (B-type) and coronary-type rupture of plaque (C-type). We hypothesized that plaque characteristics of intracranial arteries are associated with those of coronary arteries. Methods-Eighty-one patients with acute cerebral infarcts caused by intracranial atherosclerotic disease without history of CAD were analyzed. Asymptomatic CAD burden (number and degree of stenosis) and plaque characteristics (calcified, mixed, and noncalcified) were measured with multidetector computed tomography, whereas the asymptomatic intracranial atherosclerotic disease burden was measured using magnetic resonance angiography. The symptomatic intracranial artery was analyzed using high-resolution magnetic resonance imaging for vascular morphology (stenosis degree, remodeling index, and wall index) and plaque activation (enhancement pattern and volume). Results-The asymptomatic CAD burden was correlated with the asymptomatic intracranial atherosclerotic disease burden.
A therosclerosis is a systemic disease that involves the coronary and cerebral arterial systems. 1, 2 The progression of atherosclerosis in the arteries can cause myocardial and cerebral infarction, which is a great burden to the global aging society. 3 The correlation between coronary and extracranial artery atherosclerosis has been extensively explored in previous studies that reported a positive interrelation in atherosclerotic burden 4, 5 and clinical events 6-9 between 2 arteries. However, relatively little is known about the association between coronary and intracranial artery atherosclerosis. Pathological studies showed that the intracranial arteries differ from the carotid and coronary arteries both anatomically and physiologically. [10] [11] [12] [13] [14] In addition, pathological studies revealed differential responses to the vascular risk factors between the intra-and extracranial arteries 12 and a poor correlation between stenosis and histological phenotype in intracranial atherosclerosis. 15 Acute cerebral infarction caused by intracranial atherosclerosis differs from myocardial infarction and ischemic stroke caused by the extracranial arteries. Intracranial atherosclerotic stroke (ICAS) has 2 pathophysiological mechanisms with discrete clinical and radiological characteristics: one is branch occlusive disease-type (B-type), subcortical infarcts caused by parent arterial disease occluding perforator's orifice, and the other is coronary-type rupture of plaque (C-type), which is characterized by multiple embolic ischemic lesions caused by emboli from ruptured plaques of the proximal artery.
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stroke, distinctive association between myocardial infarction and intracranial atherosclerosis was reported: history of myocardial infarction was associated only with intracranial plaque not with intracranial stenosis. 18 In this study, we hypothesized that plaque phenotypes of the intracranial arteries are associated with those of the coronary arteries. Thus, we evaluated the plaque characteristics of symptomatic intracranial arteries using high-resolution magnetic resonance imaging (HR-MRI) and asymptomatic coronary atherosclerosis using cardiac multidetector computed tomography (MDCT) in patients with ICAS. 19, 20 We also tested the correlation between asymptomatic coronary artery disease (CAD) burden and intracranial atherosclerotic disease (ICAD) burden.
Methods

Study Population
Between February 1, 2011, and October 31, 2015, the patients who were admitted to a University Medical Center within 7 days of symptom onset for the treatment of acute ischemic stroke and participated in the institutional program (comprehensive Brain and Heart Health program) were enrolled in this study. The comprehensive Brain and Heart Health program is operated by an integrated team of specialized neurologists, neuroradiologists, neurosurgeons, and cardiologists who provide comprehensive evaluation and management to voluntary participating acute ischemic stroke patients. Among the subjects participating in the program, those who were diagnosed with ICAS (any degree of stenosis on relevant intracranial vessels M1 portion of middle cerebral artery or basilar artery) and underwent cardiac MDCT and HR-MRI during hospitalization were analyzed. Patients with potential sources of cardioaortic embolism, based on the Stop Stroke Study Trial of Org 10172 in Acute Stroke Treatment (SSS-TOAST), 21 extracranial atherosclerosis with significant (≥50%) stenosis in the relevant extracranial arteries, other stroke mechanisms (coagulopathy, Moyamoya disease, dissection, and others), or incomplete evaluations were excluded. We further excluded patients who had a history of CAD (eg, coronary intervention or bypass surgery), were contraindicated to cardiac MDCT or HR-MRI, were unable to cooperate because of unstable medical conditions or severe neurological deficits, or had poor-quality imaging data (eg, motion artifact). Local institutional review boards approved this study. All participants or their guardians provided informed consent to participate in the study.
Stroke Work-Ups
Clinical information including age, sex, and vascular risk factors were acquired systematically. All patients underwent standardized diagnostic tests that included routine blood tests and cardiac workups (electrocardiography, echocardiography, and ≥24-hour cardiac telemetry). All patients underwent brain MRI with diffusion-weighted imaging and magnetic resonance angiography (MRA; cervical gadolinium-enhanced MRA and 3-dimensional [3D] time-of-flight MRA of the circle of Willis).
The ischemic brain lesions on diffusion-weighted imaging were measured in terms of size, number, and cortical distribution. The number of lesions, largest diameter of each lesion, and summed ischemic lesion volume were measured using an image-analyzing program (Medical Image Processing Analysis and Visualization; Center for Information Technology, National Institutes of Health, Bethesda, MD).
We divided patients into 2 groups according to their lesion distribution on diffusion weighted imaging, in patients with symptomatic middle cerebral artery stenosis: (1) the B-type ICAS-patients with deep infarcts within the striatocapsular area, and (2) the C-type ICAS-patients with infarcts beyond the striatocapsular area (such as cortical infarctions, regardless of the presence of subcortical deep infarction). In case of posterior circulation infarction: (1) the B-type ICAS-patients with deep infarct restricted to the brain stem, and (2) the C-type-small or large scattered embolic infarcts with relevant stenosis in vertebra-basilar system.
The degree of asymptomatic ICAD burden was measured in each patient. Atherosclerotic lesions on MRA were visually graded using the following categories of ICAD score: 0=stenosis <50%; 1=stenosis of 50% to 99%; and 2=occlusion. Assessment of the ICAD location included the middle cerebral, anterior cerebral, posterior cerebral, and basilar arteries as well as the intracranial portions of the internal carotid and vertebral arteries. 22 The sum of the involved intracranial vessels scores was defined as the ICAD score.
Cardiac MDCT
Cardiac MDCT was performed using a 64-slice multidetector row CT scanner (Aquilion 64; Toshiba Medical Systems) or a dual-source CT system (Somatom Definition Flash; Siemens Medical Solutions). All cardiac MDCT results were reviewed by a single experienced radiologist who was blinded to the clinical data using a 3D workstation (Aquarius Workstation; TeraRecon). Number of coronary plaques and their characteristics (calcified, mixed, or noncalcified) were evaluated. Any structure with a density ≥130 Hounsfield units that could be visualized separately from the contrast-enhanced coronary lumen could be assigned to the coronary artery wall and identified in at least 2 independent planes was defined as a calcified plaque. For every coronary artery segment, identified via side branches, the investigators decided the number of coronary plaques and their characteristics. 23 CAD burden was categorized as no atherosclerosis or 1 segment with <50% stenosis, ≥2 segments with <50% stenosis, 1 segment with ≥50% stenosis, and ≥2 segments with ≥50% stenosis. 
High-Resolution Magnetic Resonance Imaging
HR-MRI was performed on culprit lesions located in M1 portion of middle cerebral artery or basilar artery with a 3-Tesla system (Achieva; Phillips Medical System, Best, the Netherlands) with a standard 8-channel head coil. The neuroradiologist (J.C.) selected the vessel and site of evaluation according to clinical presentation and 3D time-of-flight MRA findings and chose the combination of acquisition orientations (axial only or axial and sagittal). Black-blood HR-MRI using the spatial presaturation technique was performed. Details of HR-MRI parameters are described elsewhere. 19 The lumen and the outer vessel contours were traced manually on T2/proton density-weighted images using image-analyzing program (Medical Image Processing Analysis and Visualization). The lumen area and vessel area were automatically calculated after tracing by the program. Wall area was regarded as the difference between vessel area and lumen area (ie, wall area=vessel area-lumen area). Normal vessels located contralateral or proximal to the stenotic portion were also assessed for reference values. The stenosis degree was calculated as: (1-lumen area stenotic lesion/reference lumen area)×100%. The remodeling index was the ratio of vessel area at the stenotic lesion to the reference vessel. We defined wall area index as the ratio between the wall area of the stenotic lesion and the reference wall area. Preand postcontrast T1 fluid-attenuated inversion recovery images were compared to determine the presence or absence, enhancement pattern (concentric versus eccentric), and enhancement area. Enhancement was considered concentric if it was uniform or circumferential. Enhancement was regarded as eccentric, if it was not 360° circumferential or if the thickest part was more than twice the thinnest part where circumferential enhancement was observed. The enhancement degree was estimated as following formula: enhancement area / wall area × 100%. 19 Two neurologists (J.-W.C. and J.H.) experienced in stroke MRI reading and blinded to clinical information read the HR-MRI images. All quantitative data were remeasured 2 weeks later by a neurologist (J.-W.C.) to estimate intraobserver variability. The intraclass correlation coefficient values for measured HR-MRI parameters were examined for both inter-and intraobserver agreements, and final database was locked after achieving intraclass correlation coefficient values >0.80. 
Results
During the study period, 457 patients were recruited in the comprehensive Brain and Heart Health program; of them, 101 were diagnosed with ICAS. After the exclusion of 10 with a history of coronary heart disease and 6 with cardiac MDCT and 4 with HR-MRI findings that could not be interpreted, 81 were included in the final analysis. Among them, 48 (59.3%) were men and, the average age was 64.8±12.6 (range from 34 to 88 years), 67 (82.7%) had asymptomatic coronary atherosclerosis; 39 (48.1%) were in the B-type ICAS group and 42 (51.9%) were in the C-type ICAS group. The patients' general characteristics including medications before stroke and vascular risk factors did not differ between the 2 groups (Table 1) . Among laboratory findings total cholesterol and low-density lipoprotein cholesterol levels were higher in B-type ICAS group.
The overall distribution of asymptomatic CAD burden was similar in the 2 ICAS groups (P=0.343; Table 2 ). To directly assess the correlation between atherosclerotic burden in coronary and intracranial arteries, ICAD scores were compared between CAD burden categories ( Figure 1 ). The ICAD score was positively correlated with CAD burden (P for trend, <0.001, for both ICAD score categories).
The asymptomatic coronary plaque compositions differed between B-and C-type ICAS ( We compared the characteristics of symptomatic intracranial atherosclerotic vessels and ischemic brain lesions according to the number of noncalcified coronary plaques in overall ICAS patients (Table 3) 
021).
Based on these results, multivariable logistic regression analysis was performed to determine the independent association between coronary atherosclerotic plaque composition and ICAS phenotype. After adjusting for covariates (age, total cholesterol level, and ICAD score), the presence of a noncalcified plaque (odds ratio, 3.38; 95% confidence interval, 1.05-10.85; P=0.041) remained independently associated with C-type ICAS (Table 4) . Representative cases of the study findings are demonstrated in Figure 2 .
Discussion
The major findings of this study were as follows. First, asymptomatic coronary atherosclerosis is common in patients with ICAS (>80%) and asymptomatic CAD burden is correlated with asymptomatic ICAD burden. Second, the coronary plaque composition (calcified versus noncalcified) is correlated with that of intracranial plaques (B-type versus C-type ICAS). Furthermore, as the number of coronary noncalcified plaques increased, positive remodeling with vessel wall thickening accompanied by plaque enhancement increased in the symptomatic arteries of patients with ICAS.
In this study, plaque characteristics and atherosclerotic burden of the intracranial artery were investigated in relation to coronary artery atherosclerosis. The intracranial artery has been reported to have distinct characteristics compared with the extracranial carotid, coronary, and systemic arteries. [10] [11] [12] [13] Less extensive and later occurring atherosclerosis of the intracranial artery has been explained by a difference in atherogenic response to hypercholesterolemia and greater activity of the antioxidant enzymes within the intracranial arteries. 12, 13 Furthermore, substantial global variation in the relative burden of stroke compared with ischemic heart disease may exist. It was reported that stroke burden as disproportionately higher in East Asian, Africa, and South America, whereas ischemic heart burden was higher in the Middle East, North America, Australia, and much of Europe. 25 As a result, previous studies have focused on differentiating risk factors between cerebral atherosclerosis, especially intracranial atherosclerosis and coronary atherosclerosis. 26 However, our results indicate that the coronary and intracranial arteries share atherosclerotic burden and plaque Values are mean±SD unless noted otherwise. CAD indicates coronary artery disease; ICAD, intracranial atherosclerotic disease; ICAS, intracranial atherosclerotic stroke; and IQR, interquartile range. Figure 1 . Asymptomatic intracranial atherosclerotic burden score by coronary atherosclerosis burden score. Atherosclerotic lesions on magnetic resonance angiography were graded using 2 different methods: Method 1 for intracranial atherosclerotic stroke of any degree, 0=no stenosis, 1=stenosis <50%, 2=stenosis 50% to 99%, and 3=occlusion; method 2 for intracranial atherosclerotic disease (ICAD) ≥50%, 0=stenosis <50%, 1=stenosis 50% to 99%, and 2=occlusion.
by guest on October 2, 2017 http://stroke.ahajournals.org/ Downloaded from characteristics. Coronary artery plaque composition determined the ICAS phenotype. In addition, although follow-up information about the occurrence of acute coronary syndrome of our patients was not available, it is possible that patients with C-type ICAS show a higher risk of coronary events than those with B-type ICAS. These findings call for comprehensive management of atherosclerotic disease in the brain and heart based on plaque vulnerability (stable versus unstable) not by the location of atherosclerotic artery.
Limitations
This study has several limitations. First, it was a single-center based study with a limited sample size. During the 5 years of recruitment in our comprehensive Brain and Heart Health program, the data of only 81 were available for the analyses. The limited number of subjects may not have provided sufficient comparison of atherosclerotic disease between CAD and ICAD. However, in this study, an extensive evaluation of atherosclerotic burden using both cardiac MDCT and intracranial HR-MRI examination was performed of a specific population of patients, patients with acute ICAS. We think that this study shows one of the largest cohorts of recent studies using HR-MRI. [27] [28] [29] Second, the results of this study should be interpreted with caution because the relative distribution of 
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intracranial and coronary atherosclerosis may differ between Asians and Westerners. The prevalence of intracranial atherosclerosis is high in Asians. 30 Future studies with diverse races and ethnicities are warranted to confirm the findings of this study. Third, plaque characteristics in symptomatic intracranial and asymptomatic coronary arteries were evaluated in this study. Different characteristics between symptomatic and asymptomatic plaques in the 2 arteries could have influenced, at list in part, findings of this study. Last but not the least, the possibility of selection bias cannot be ruled out because patients with ICAS were not consecutively included in the study. By including only patients participating in the program, those who are more committed to their treatment and willing to undergo a comprehensive evaluation could have been selected, which may cause deviation in our study population. Nevertheless, considering the medical charges and risk of potential side effects of imaging studies, such a study with extensive atherosclerotic plaque evaluation could be only done in a limited population. Furthermore, the patient characteristics did not differ between study participants and nonparticipants among those admitted during the study period except for ICAS phenotype (Table I in the online-only Data Supplement).
Conclusions
Our data indicate that the atherosclerotic burden and the plaque characteristics of the coronary artery behave in similar ways with intracranial artery, in patients with ICAS. Our results suggests the need to evaluate other vascular trees in patients with vulnerable plaques in 1 arterial system and control systemic factors, rather than treat 1 arterial system. Furthermore, the underlying systemic factors promoting atherosclerotic changes in the coronary and intracranial arteries remain to be explored. 
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